Hexagon Nutrition IPO: Key Risks and Considerations for Investors Ahead of Subscription
Hexagon Nutrition
IPOHexagon Nutrition's Initial Public Offering (IPO) Set to Open on June 5
Hexagon Nutrition's initial public offering (IPO) is scheduled to open for subscription on Friday, June 5, and will conclude on Tuesday, June 9. The company aims to raise ₹139 crore through the offer, with the price band set at ₹42-45 per equity share. The IPO consists solely of an offer for sale (OFS) of up to 30.86 million equity shares, with existing shareholders Arun Purushottam Kelkar, Subhash Purushottam Kelkar, Aditya Kelkar, and Nutan Subhash Kelkar looking to pare their holdings.
The basis of allotment is expected to be finalized on June 10, with the company's shares scheduled to debut on the BSE and NSE on June 12. Investors can bid for a minimum of 333 shares, requiring an investment of ₹14,985 at the upper end of the price band.
Founded in 1993, Hexagon Nutrition operates as a research-driven nutrition company with a portfolio spanning micronutrient premixes, therapeutic nutrition products, and clinical nutrition offerings. The company's IPO offers investors exposure to India's growing nutrition, wellness, and micronutrient market.
However, the Red Herring Prospectus (RHP) highlights several risks that investors should carefully evaluate before investing.
| Risk | Description |
|---|---|
| 1. Heavy Dependence on Premix Formulations Business | The company derives a significant portion of its revenue from its premix formulations segment, which could be impacted by slowdown in demand, pricing pressure, customer loss, regulatory changes, or increased competition. |
| 2. Exposure to Foreign Exchange Fluctuations | Hexagon operates across more than 70 countries and is exposed to foreign exchange fluctuations, which can affect both import costs and export realizations. |
| 3. Risks Associated With Overseas Operations | The company operates subsidiaries and manufacturing facilities in countries with geopolitical risks, local regulations, economic instability, currency controls, taxation changes, and difficulties in enforcing contracts. |
| 4. Loss-Making Foreign Subsidiaries | Some overseas subsidiaries have reported losses in recent years, which could require additional capital support through equity infusion, loans, advances, or guarantees. |
| 5. Dependence on Raw Material Availability and Pricing | The company relies on a wide range of raw materials, including vitamins, whey protein, maize starch, lactose, and cocoa powder, which could be affected by disruptions in availability, increases in commodity prices, logistics issues, import restrictions, or supplier concentration. |
| 6. Manufacturing Facility Concentration Risk | The company operates three manufacturing facilities in India and one in Uzbekistan, which could be impacted by disruptions arising from accidents, natural disasters, equipment failures, labour issues, regulatory action, power shortages, or quality failures. |
| 7. New Product Launches May Not Succeed | The company has recently launched the NUTRONE brand and several new products, which may not gain market traction and could lead to inventory write-offs, marketing losses, and reduced returns on investment. |
| 8. Intellectual Property and Confidentiality Risks | The company relies on proprietary formulations, product recipes, trademarks, and technical know-how, which could be weakened by leakage of confidential information, inability to protect intellectual property rights, or infringement claims by third parties. |
| 9. Ongoing Legal Proceedings | The RHP discloses ongoing legal proceedings involving the company, subsidiaries, promoters, directors, and senior management, which could result in financial liabilities, reputational damage, management distraction, and increased compliance costs. |
| 10. Profitability Improvement May Not Be Sustainable | Hexagon's profitability has improved significantly in recent years, but the company cautions that these gains may not continue indefinitely due to factors such as favourable product mix, better procurement, higher capacity utilization, and operational efficiencies. |
Investor Takeaway
Investors should carefully consider the risks and factors before subscribing to the Hexagon Nutrition IPO.
More in IPO
SpaceX Seeks Record $75 Billion IPO, Potentially Positioning Elon Musk as the World's First Trillionaire
SMR Jewels IPO Successfully Lists with Institutional Support
Zepto Nears $1 Billion Quarterly Net Order Value Milestone Before IPO
